Also available in Persian — نسخه فارسی ✈️ Telegram EN فا
ISNA is a semi-official Iranian news agency (Iranian Students News Agency). This is a translation of that outlet's own report; it is the outlet's account, not Artesh's finding. See what Iranian state media is saying today.
❓ Unknown

Dissolving Drug for Clots Did Not Shorten Hospitalization Duration for Children with Lung Infections

14h ago November 4, 2026 1 min read 📰 ISNA
📋 Key Takeaway

A study on 85 children with lung infections found that adding alteplase to saline washing did not significantly reduce hospitalization time compared to saline alone. This research is important as it questions the effectiveness of the treatment method for such infections.

🔍 Quick Context Guide
💡 Bottom Line: The study raises questions about the effectiveness of a commonly used treatment for lung infections in children.

👥 Key Players

Children's Medical Center, Tehran MENTIONED
Research institution conducting the study
"A leading pediatric medical facility in Iran, contributing to advancements in child healthcare."
Researchers involved in the study MENTIONED
Medical professionals and scientists
"They are critical in evaluating treatment efficacy and improving healthcare outcomes for children."

📰 What Happened

A study involving 85 children with lung infections found that adding the drug alteplase to saline washing did not significantly shorten hospitalization duration compared to saline alone. The researchers caution that this does not equate the two treatment methods.

  • The study involved 85 children with complicated pleural space infections.
  • The findings challenge the perceived effectiveness of alteplase in treating such infections.

💡 Why It Matters

🇮🇷 For Iran: The findings may influence treatment protocols for lung infections in children, impacting healthcare practices and resource allocation.
🌍 Regional: If adopted, these findings could affect pediatric healthcare strategies across the region, potentially improving health outcomes.
🌐 International: International medical communities may reassess the use of alteplase in similar cases, affecting global treatment guidelines.

📚 Background

Alteplase is a thrombolytic agent often used to dissolve blood clots, and its application in treating lung infections is being explored. Understanding the efficacy of such treatments is crucial for improving pediatric healthcare.

Pediatric healthcare advancements Treatment efficacy in respiratory infections
📡 Source: NEUTRAL
📊 Confidence: 70%
The study is based on scientific research, suggesting a focus on factual reporting rather than political bias.

Results from a study by researchers at the Children's Medical Center in Tehran on 85 children with complicated pleural space infections showed that adding the drug alteplase to saline washing of the lung's surrounding space does not significantly reduce the hospitalization duration of patients compared to using saline alone; however, the researchers emphasize that this finding does not prove the equivalence of the two treatment methods.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 85%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →